Guangzhou Ribobio

Guangzhou Ribobio is a leading Chinese biotechnology company specializing in RNA interference (RNAi) technologies and oligonucleotide therapeutics. Founded in 2004 by Dr. Zicai Liang, the company has established a comprehensive vertical integration platform for oligonucleotide drug development, including discovery, optimization, and large-scale GMP manufacturing. Ribobio operates as both a drug developer with a proprietary pipeline and a premier CDMO/CRO service provider for the global life sciences industry. Their portfolio targets a wide range of indications such as metabolic diseases, infectious diseases, and oncology. The company is recognized for its advanced delivery technologies, such as the GalNAc platform, and its role in advancing the RNAi field within Asia. Ribobio continues to expand its global footprint through strategic partnerships and state-of-the-art manufacturing facilities.